Article
Perspectives on genetic studies of type 2 diabetes from the genome-wide association studies era to precision medicine.
Journal of diabetes investigation - 1 Apr 2024
Imamura Minako, Maeda Shiro
Abstract excerpt
Genome-wide association studies (GWAS) have facilitated a substantial and rapid increase in the number of confirmed genetic susceptibility variants for complex diseases. Approximately 700 variants predisposing individuals to the risk for type 2 diabetes have been identified through GWAS until 2023. From 2018 to 2022, hundreds of type 2 diabetes susceptibility loci with smaller effect sizes were identified through...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
